<DOC>
	<DOCNO>NCT00626080</DOCNO>
	<brief_summary>The aim study test hypothesis subcutaneous administration insulin detemir , compare insulin NPH , lead pronounced effect cerebral glucose metabolism and/or cerebral blood flow brain region associate appetite regulation , account report difference weight .</brief_summary>
	<brief_title>Insulin Detemir Action Cerebro</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Isophane insulin , beef</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Isophane Insulin , Human</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<criteria>Type 1 diabetic patient ; Diabetes duration =/ &gt; 1 year ; HbA1c ~ 7,5 % ; Recent onset DM ; BMI &lt; 18 OR &gt; 35 kg/m2 ; T2DM ; History major heart/renal disease ; Severe untreated proliferative retinopathy ; History recurrent severe hypoglycaemia ; ( History ) brain disorder ; Alcohol abuse , ( History ) drug abuse , benzodiazepine , selective betablockers , oral steroid , oral anticoagulant ; Current psychiatric disease/treatment ; ( history ) eating disorder ; History severe head trauma accompany loss consciousness ; Any endocrine disease well control least 3 month ; Inability undergo MRI ; Visual acuity &lt; 0.3 ; Known suspect allergy trial product relate product</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Insulin</keyword>
	<keyword>Detemir</keyword>
	<keyword>Brain</keyword>
	<keyword>Glucose metabolism</keyword>
</DOC>